Myeloproliferative Disorders Flashcards

1
Q

3 types of myeloid neoplasms

A
  1. AML
  2. Myelodysplastic syndrome
  3. Myeloproliferative disorders
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

is characterized by blasts that replace bone marrow & suppress normal hematopoiesis.

A

AML

(myeloproliferative disorders are tumors that increase myeloid elements, ex: CML)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

CML is a myeloproliferative disorders where myeloid tumors increase _____.

A

myeloid elements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

In myeloid neoplasms, what are 2 factors that determine the type of disease (AML, myelodysplastic, or myeloproliferative)

A
  1. Hierarchical position of transformed cell (stem cell or further down lineage)
  2. effect of transforming event on differentiation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

4 myeloproliferative disorders

A
  1. CML
  2. Polycythemia vera
  3. Essential thrombocytosis
  4. Primary myelofibrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mutation in CML? Consequence?

A
  1. BCR-ABL fusion gene
  2. ABL kinase activation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which 3 myeloproliferative disorders have a JAK2 point mutation (consequence = JAK2 kinase activation)?

A
  1. Polycythemia vera
  2. Essential thrombocythemia
  3. Primary myelofibrosis

(Or MPL point mutations → MPL kinase activation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Mutation in Systemic Mastocytosis? Consequence?

A

KIT point mutation → KIT kinase activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Mutation in Chronic eosinophilic leukemia? Consequence?

A

FIP1L1-PDGFRA fusion gene → PDGFRa kinase activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Mutation in Stem cell leukemia? Consequence?

A

FGFR1 fusion gene → FGFR1 kinase activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

BCR-ABL (Philadelphia chromosome) is the cause of _______ (disease)

A

CML

(short chromosome 22)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

In CML, constitutive activation of BCR-ABL → activation of which pathways (2)?

A
  1. RAS
  2. JAK-STAT

(leads to proliferation of granulocytic & megakaryocytic precursors → immature granulocytes in blood (bands))

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which myeloproliferative disorder is dx w/PCR or chromosome analysis?

A

CML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which Myeloproliferative disorder has leukocytosis, blasts, and anemia

A

CML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

CML typically affects which age group? Polycythemia Vera? Primary myelofibrosis?

A
  • 50-60s
  • Late middle age
  • >60
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

CML is a neoplastic proliferation of myeloid precursors which would normally go on to become ______ (3).

A
  1. monocyte
  2. erythrocyte
  3. megakaryocyte
17
Q

CML symptoms (3)

A
  1. splenomegaly (“dragging” sensation)
  2. weakness
  3. weight loss

(primary myelofibrosis also has splenomegaly)

18
Q

______ exposure is a risk factor of CML

A

benzene

19
Q

Which myeloproliferative disorders are treated with tyrosine kinase inhibitors and which are treated with phlebotomy?

A

TKI: all but polycythemia vera, which is treated with phlebotomy

20
Q

Imatinib is a tyrosine kinase inhibitor that targets _______ protein.

A

BCR-ABL

(possible resistance mutation: T315l)

21
Q

Goal of therapy w/Imatinib

A
  1. complete hematological response after 3 months
  2. complete cytogenic response after 6 months

(possible resistance if the mutation is T315I)

22
Q

Panmyelosis, increased Hct and HTN indicates which myeloproliferative disorder?

A

Polycythemia vera

(panmyelosis = RBCs, granulocytes & platelets)

23
Q

Polycythemia vera: sx (3)

A
  1. cyanosis (due to hyperoxygenation)
  2. bleeding
  3. thrombotic episodes
24
Q

Essential thrombocytosis: sx (3)

A

dysfunctional platelets (thrombosis & hemorrhage)

(NO myelofibrosis (marrow fibrosis) or polycythemia vera (lack of panmyelosis)

25
Q

Which myeloproliferative disorders has a very high lab value of platelets?

A

essential thrombocytosis

26
Q

Primary myelofibrosis: sx (2)

A
  1. anemia
  2. splenomegaly (due to extramedullary hematopoiesis)
27
Q

Early Primary Myelofibrosis labs will show _______ (2). Late? Very late?

A
  • Leukocytosis & thrombocytosis
  • Hypocellular & fibrotic marrow
  • osteosclerosis
28
Q

Which myeloproliferative disease is characterized by teardrop shaped RBCs (aka Dacrocytes) & nucleated RBCs on blood smear?

A

Primary myelofibrosis

29
Q
A
30
Q
A
31
Q
A
32
Q
A
33
Q
A